DECONGESTANT MARKET ANALYSIS

Decongestant Market, By Product Type (Tablets, Capsules, Nasal Sprays and Others), By Type of Decongestant (Oral Decongestants ( Pseudoephedrine, Phenylephrine and Others), Nasal Decongestants ( Oxymetazoline, Xylometazoline, Phenylephrine, Naphazoline and Others)), By Mode of Action (Alpha-Adrenergic Agonists, Vasoconstrictors, and Others), By Application (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Sinusitis, Nasal Congestion, Cold and Flu and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Hyper Market/Super Market), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023
Code : CMI5805
Pages :170
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc, Prestige Consumer Healthcare Inc., Procter & Gamble Co., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Perrigo Company plc, Church & Dwight Co., Inc., Mylan N.V. Marinomed Biotech AG, Dr. Reddy’s Laboratories Ltd.